Hint mode is switched on Switch off

INmune Bio, ordinary share
INMB, US45782T1051

Add a stock to WL
Choose all Reset all
INmune Bio, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer.
  • Issuer
  • Full borrower / issuer name
    INmune Bio Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    INMB
  • Placement
    04.02.2019
  • Lock up period
    180
  • Number of papers
    1,020,560
  • Volume of raised funds
    8.16 mln USD
  • Placement share
    9.1%
  • Final placement price
    8 USD
  • Price change since placement date
    -84.56%
  • By capitalization
    89.76 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    INMB
  • Placement
    16.07.2020
  • Lock up period
    180
  • Number of papers
    2,173,914
  • Volume of raised funds
    21.74 mln USD
  • Placement share
    16.6%
  • Final placement price
    10 USD
  • Price change since placement date
    -87.65%
  • By capitalization
    130.99 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    INMB
  • Placement
    22.04.2024
  • Lock up period
    180
  • Number of papers
    18,774,985
  • Volume of raised funds
    4.76 mln USD
  • Placement share
    3.04%
  • Final placement price
    8.32 USD
  • Price change since placement date
    -85.16%
  • By capitalization
    156.21 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    INMB
  • Placement
    16.09.2024
  • Lock up period
    180
  • Number of papers
    2,341,260
  • Volume of raised funds
    12.88 mln USD
  • Placement share
    10.56%
  • Final placement price
    5.5 USD
  • Price change since placement date
    -77.55%
  • By capitalization
    121.95 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
IV q eng
Show all Hide

Related Stock indices

Indicators

News

29/04/2026 INmune Bio: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
19/12/2025 INmune Bio: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
05/12/2025 INmune Bio: Termination Of A Material Definitive Agreement
05/12/2025 INmune Bio: Entry Into A Material Definitive Agreement, Material Modification To Rights Of Security Holders, Financial Statements And Exhibits
26/11/2025 INmune Bio: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.